Apnimed, Inc. (APMD) stock
APMDNasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Sep 8, 2026
$16.78+0.92 (+5.80%)
Close on Nov 11, 2026Market cap $80.57MP/E –Yield –
Key statistics
Valuation at the latest close; fundamentals over fiscal , balances at Jun 30, 2026
Valuation
- Market cap
- $80.57M
- P/E ratio
- –
- Price to sales
- –
- Price to book
- –
- Dividend yield
- –
- Free cash flow yield
- –
Fundamentals
- Book value per share
- -$5.45
- Diluted shares
- 32M
Trading
- Previous close
- $15.86
- Open
- $15.99
- Day's range
- $15.26 – $16.88
- Volume
- 195,574
- Average volume (20 days)
- 371,645
- RSI (14 days)
- 44.7
- Relative volume
- 0.39×
Total return vs. the S&P 500
Price change plus reinvested dividends, to the close on Nov 11, 2026. The S&P 500 is measured by the SPY fund.
| Period | APMD | S&P 500 | Difference | APMD per year | S&P 500 per year |
|---|---|---|---|---|---|
| 1 month | -9.4% | -2.4% | −7.0 pts | ||
| 3 months | -32.5% | -1.2% | −31.4 pts |
Two years at a glance
Fiscal years 2024 to 2025, USD
Reported period
Press releases
Releases Apnimed filed with the SEC as exhibits to Form 8-K or 6-K
Apnimed stock: common questions
What is Apnimed's stock price?
APMD closed at $16.78 on Nov 11, 2026, up 5.80% on the day.
What is Apnimed's market cap?
Apnimed was worth $80.57M at the close on Nov 11, 2026: the share price times the diluted shares outstanding.
Does Apnimed pay a dividend?
No. Apnimed has not paid a cash dividend over the last twelve months.
Who are Apnimed's competitors?
Companies most similar to Apnimed by business, industry and size include LLY, JNJ, ABBV, MRK, AZN.
See a number that looks wrong?